semaglutide elisa cross-reactivity Long-acting hydrogel-based depot formulations of tirzepatide and for the management of type 2 diabetes and weight Development of an electrochemiluminescence immunoassay

Start a weight-loss clinic offering GLP-1 treatments like semaglutide in Michigan

Hear what Derek Tice had to say about these new challenges in the insurance industry.

New research challenges fears about Ozempic weight regain

Join the GLP-1 Strength Program to maintain muscle while losing weight

Taking weight loss medicines can avert the long process of dealing with the FAA in cases of heart disease or diabetes

Conclusion Compared with DPP4i, semaglutide was associated with lower follow-up HbA1c and BMI, greater reduction in HbA1c and BMI from baseline, and reduced likelihood of requiring treatment augmentation or insulin initiation to manage T2D in US adults, suggesting better durability of semaglutide vs DPP4i